AzTrials
AzTrials

Frail Elderly SyndromeNCT03365505

Frailty Assessment in Elderly Patients With Acute Coronary Syndrome

An observational study of Frail Elderly Syndrome and Acute Coronary Syndrome, run by Meir Medical Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Frailty is known as an independent risk factor for morbidity and mortality in older cardiac patients . It is an important factor on the cardiologist decision between conservative and invasive treatment in older patient with acute coronary syndrome, and is usually made subjectively by the cardiologist known in the… Read more about this study

Who is it for?
Ages 80 to 120 years
How many people
200 participants
Where
No sites listed yet
Study dates
15 Dec 2017to 15 Sep 2018
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 80 to 120 years
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: elderly patient admitted to our hospital with acute coronary syndrome: unstable angina or non ST elevation myocardial infarction who are aged 80 and above and are hemodinamically stable.

Who may be able to join

  • patient admitted to Meir hospital with acute coronary syndrome
  • Age: 80 years old and older
  • eligible for signing an informed concent

Who cannot join

  • uncontrolled heart failure ( pulmonary edema or the use of iv diuretics)
  • cardiogenic shock
  • fever st elevation myocardial infarction

About this study

Frailty is known as an independent risk factor for morbidity and mortality in older cardiac patients . It is an important factor on the cardiologist decision between conservative and invasive treatment in older patient with acute coronary syndrome, and is usually made subjectively by the cardiologist known in the literature as eyeball testing.

in this study the investigators will compare the cardiologists eye ball testing to objective frailty assessment based on Fried score and Edmonton frailty scale.

Read the detailed description

elderly patients admitted to Meir hospital with acute coronary syndrome will be assessed for frailty twice: the first frailty assessment will be a subjective eye ball testing made by the cardiologist, the second assessment will be an objective one based on Fried frailty score and Edmonton frail scale.

The cardiologist will not be aware of the objective frailty assessment result.

The eye ball testing will be compared to the objective frailty assessment (Fried score and Edmonton frailty scale).

Medical subject headings
Acute Coronary Syndrome

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. A subjective eye ball frailty assessment will be compared to an objective frailty assessment based on Fried score and Edmonton frailty scale

    Subjective frailty assessment made by a cardiologist during hospitalization with acute coronary syndrome- "eye ball" testing

    Measured: Through hospitalization , an average of 1 week

  2. An objective frailty assessment using Fried score and Edmonton frailty scale will be compared to a subjective eye ball frailty assessment

    An objective frailty assessment based on Fried score and Edmonton frailty scale

    Measured: Through hospitalization , an average of 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Dec 2017
  2. Study start15 Dec 2017 (estimated)
  3. Primary completion15 Sep 2018 (estimated)
  4. Study completion15 Sep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
200 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT03365505
Sponsor's protocol ID
00-34-17-MMC
Status last verified
Dec 2017
First submitted
28 Nov 2017
Last updated
7 Dec 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Frail Elderly Syndrome and Acute Coronary Syndrome, run by Meir Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

A subjective eye ball frailty assessment will be compared to an objective frailty assessment based on Fried score and Edmonton frailty scale (time frame: Through hospitalization , an average of 1 week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in